Back to Search Start Over

Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.

Authors :
Reger De Moura C
Louveau B
Jouenne F
Vilquin P
Battistella M
Bellahsen-Harrar Y
Sadoux A
Menashi S
Dumaz N
Lebbé C
Mourah S
Source :
Oncogene [Oncogene] 2024 May; Vol. 43 (21), pp. 1620-1630. Date of Electronic Publication: 2024 Apr 03.
Publication Year :
2024

Abstract

The role of the focal adhesion protein kindlin-3 as a tumor suppressor and its interaction mechanisms with extracellular matrix constitute a major field of investigation to better decipher tumor progression. Besides the well-described role of kindlin-3 in integrin activation, evidence regarding modulatory functions between melanoma cells and tumor microenvironment are lacking and data are needed to understand mechanisms driven by kindlin-3 inactivation. Here, we show that kindlin-3 inactivation through knockdown or somatic mutations increases BRAF <superscript>V600mut</superscript> melanoma cells oncogenic properties via collagen-related signaling by decreasing cell adhesion and enhancing proliferation and migration in vitro, and by promoting tumor growth in mice. Mechanistic analysis reveals that kindlin-3 interacts with the collagen-activated tyrosine kinase receptor DDR1 (Discoidin domain receptor 1) modulating its expression and its interaction with β1-integrin. Kindlin-3 knockdown or mutational inactivation disrupt DDR1/β1-integrin complex in vitro and in vivo and its loss improves the anti-proliferative effect of DDR1 inhibition. In agreement, kindlin-3 downregulation is associated with DDR1 over-expression in situ and linked to worse melanoma prognosis. Our study reveals a unique mechanism of action of kindlin-3 in the regulation of tumorigenesis mediated by the collagen-activated tyrosine kinase receptor DDR1 thus paving the way for innovative therapeutic targeting approaches in melanoma.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
1476-5594
Volume :
43
Issue :
21
Database :
MEDLINE
Journal :
Oncogene
Publication Type :
Academic Journal
Accession number :
38570692
Full Text :
https://doi.org/10.1038/s41388-024-03014-3